Filing Details
- Accession Number:
- 0001209191-18-055403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 17:52:44
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-17 17:52:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1333482 | J Kimberly Popovits | 301 Penobscot Dr. Redwood City CA 94063 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-15 | 25,000 | $22.98 | 201,982 | No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-15 | 23,720 | $64.26 | 178,262 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-15 | 880 | $64.79 | 177,382 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-15 | 400 | $65.76 | 176,982 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Acquisiton | 2018-10-16 | 25,000 | $22.98 | 201,982 | No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-16 | 2,795 | $64.45 | 199,187 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-16 | 6,103 | $65.41 | 193,084 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-16 | 8,217 | $66.43 | 184,867 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2018-10-16 | 7,885 | $67.39 | 176,982 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-10-15 | 25,000 | $0.00 | 25,000 | $22.98 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-10-16 | 25,000 | $0.00 | 25,000 | $22.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
65,000 | 2021-01-27 | No | 4 | M | Direct | |
40,000 | 2021-01-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 59,517 | Direct | |
Common Stock | 12,298 | Indirect | Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 14, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $63.64 to $64.63.
- Represents weighted average sale price. Actual sale prices ranged from $64.64 to $65.55.
- Represents actual sale price.
- Represents weighted average sale price. Actual sale prices ranged from $63.97 to $64.96.
- Represents weighted average sale price. Actual sale prices ranged from $64.97 to $65.96.
- Represents weighted average sale price. Actual sale prices ranged from $65.97 to $66.96.
- Represents weighted average sale price. Actual sale prices ranged from $66.97 to $67.73.
- Includes an aggregate of 51,204 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.